RCUS4:05 PMArcus Biosciences Reports Second-Quarter 2026 Financial Results and Provides a Pipeline Updatearcusbio.com
RCUS4:35 PMArcus Biosciences Announces Clinical Supply Agreement with AVEO Oncology to Evaluate Casdatifan in Combination with Tivozanib for Advanced Kidney Cancer Patientsarcusbio.com
RCUS4:30 PMArcus Biosciences and Summit Therapeutics Enter Into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancerarcusbio.com
RCUS4:05 PMArcus Biosciences to Host Conference Call to Discuss Second-Quarter 2026 Financial Results and Pipeline Updatesarcusbio.com
RCUS11:00 AMNew Research Published in Nature Links Clinical Activity with HIF‑2a Biology in Advanced Kidney Cancer Patients Treated with Casdatifanarcusbio.com